BOSTON, MA—Patients with significant symptomatic degenerative mitral regurgitation (MR) who had complex anatomy making them ineligible for inclusion in the CLASP IID trial can be treated safely and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback